Works matching IS 10781552 AND DT 2016 AND VI 22 AND IP 5

Results: 11

Comparison of two different formulas for body surface area in adults at extremes of height and weight.
Published in:
Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 5, p. 690, doi. 10.1177/1078155215599669
By:
- Fancher, Karen M.;
- Sacco, Alicia J.;
- Gwin, Robert C.;
- Gormley, Luke K.;
- Mitchell, Caitlin B.
Publication type:
Article
Use of vemurafenib in a patient unable to swallow whole.
Published in:
Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 5, p. 733, doi. 10.1177/1078155215603231
By:
- Janson, Brett;
- Whittle, James;
- Witney, Kate;
- Moodie, Kate;
- Callahan, Jason;
- Sandhu, Shahneen
Publication type:
Article
Comparative effectiveness of granulocyte colony-stimulating factors to prevent febrile neutropenia and related complications in cancer patients in clinical practice: A systematic review.
Published in:
Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 5, p. 702, doi. 10.1177/1078155215625459
By:
- Mitchell, Sarah;
- Li, Xiaoyan;
- Woods, Matthew;
- Garcia, Jacob;
- Hebard-Massey, Kerri;
- Barron, Rich;
- Samuel, Miny
Publication type:
Article
Randomized controlled trials in relapsed/refractory follicular lymphoma: a systematic review and meta-analysis.
Published in:
Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 5, p. 666, doi. 10.1177/1078155215603230
By:
- Police, Rachel L.;
- Trask, Peter C.;
- Wang, Jianmin;
- Olivares, Robert;
- khan, Shahnaz;
- Abbe, Adeline;
- Colosia, Ann;
- Njue, Annete;
- Sherril, Beth;
- Ruiz-Soto, Rodrigo;
- Kaye, James A.;
- Hamadani, Mehdi
Publication type:
Article
Comorbidities among patients with cancer who do and do not develop febrile neutropenia during the first chemotherapy cycle.
Published in:
Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 5, p. 679, doi. 10.1177/1078155215603229
By:
- Li, Xiaoyan;
- Luthra, Rakesh;
- Morrow, Phuong K.;
- Fisher, Maxine D.;
- Reiner, Maureen;
- Barron, Richard L.;
- Langeberg, Wendy J.
Publication type:
Article
Stability of four standardized preparations of methotrexate, cytarabine, and hydrocortisone for intrathecal use.
Published in:
Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 5, p. 659, doi. 10.1177/1078155215600905
By:
- Olmos-Jiménez, Raquel;
- Espuny-Miró, Alberto;
- Díaz-Carrasco, María Sacramento;
- Fernández-Varón, Emilio;
- Valderrey-Pulido, Manuel;
- Cárceles-Rodríguez, Carlos
Publication type:
Article
Evaluation of empiric antibiotic de-escalation in febrile neutropenia.
Published in:
Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 5, p. 696, doi. 10.1177/1078155215597558
By:
- Kroll, Amanda L.;
- Corrigan, Patricia A.;
- Patel, Shejal;
- Hawks, Kelly G.
Publication type:
Article
Tyrosine kinase inhibitor-associated syndrome of inappropriate secretion of anti-diuretic hormone.
Published in:
Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 5, p. 729, doi. 10.1177/1078155215592023
By:
- Hill, Jordan;
- Shields, Jenna;
- Passero, Vida
Publication type:
Article
Systemic capillary leak syndrome in a patient receiving adjuvant oxaliplatin for locally advanced colon cancer.
Published in:
Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 5, p. 725, doi. 10.1177/1078155215591388
By:
- Anderson, Brandon J.;
- Peterson, Lindsay L.
Publication type:
Article
Fatal pulmonary toxicity due to carfilzomib (Kyprolis™).
Published in:
Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 5, p. 720, doi. 10.1177/1078155215588630
By:
- Lataifeh, Abdel Rahman;
- Nusair, Ahmad
Publication type:
Article
A first case report of diffuse acneiform eruption caused by capecitabine in a patient with small-cell neuroendocrine lung carcinoma.
Published in:
Journal of Oncology Pharmacy Practice, 2016, v. 22, n. 5, p. 717, doi. 10.1177/1078155215587542
By:
- Kara, Asude;
- Alatas, EmineTugba;
- Dogan, Gursoy;
- Celik, Serkan Y.;
- Tanriverdi, Ozgur
Publication type:
Article